qXR-LN
Overview
qXR-LN by Qure.ai is a cutting-edge computer-aided detection (CAD) software designed to identify and highlight regions indicative of suspected pulmonary nodules, ranging from 6 to 30 mm in size, on frontal chest X-rays of adults. This AI tool acts as a secondary reader, assisting physicians such as radiologists, pulmonologists, and emergency room physicians in the review of chest X-rays, particularly for the incidental detection of lung nodules. It is not intended to be used on a standalone basis for clinical decision-making or to rule out target conditions, but rather to complement the expertise of medical professionals by providing adjunctive information. qXR-LN integrates seamlessly into existing standard of care workflows, offering pre-read assistance and serving as a passive notification system for worklist prioritization, ultimately aiming to support earlier identification of lung cancers and improve patient outcomes.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-powered detection and localization of lung nodules (6-30mm) on chest X-rays
- Acts as a secondary reader to aid physicians
- Provides pre-read assistance within seconds
- Identifies incidental findings for lung cancer
- Integrates into existing standard of care workflow for worklist prioritization
- Can be deployed on cloud or on-premise
- Offers multilingual support on mobile and web (for qXR platform)
- Produces DICOM format outputs
- Compatible with any DICOM viewer or PACS
- Clinically validated in multiple geographies
Use Cases
- Early detection of lung cancer
- Screening for pulmonary nodules on chest X-rays
- Assisting radiologists in reviewing chest X-rays
- Aiding pulmonologists and ER physicians in nodule detection
- Workflow triage by flagging suspected findings
- Reducing time to diagnosis in critical settings
What Physicians Need to Know
qXR-LN serves as a valuable 'second pair of eyes' for detecting lung nodules on chest X-rays, potentially improving early lung cancer detection. It can be particularly useful for triaging patients due to its high negative predictive value, helping to rule out malignancy. Physicians should remember that qXR-LN provides adjunctive information and should not be used as a standalone diagnostic tool. Integrating this AI tool into existing workflows can help prioritize cases and potentially reduce diagnostic oversights, especially in high-volume settings or when reviewing incidental findings.
qXR-LN is designed for seamless integration into existing radiology workflows. It is hardware agnostic and can be deployed on-premise or via the web, with direct PACS integration. The output is in DICOM format, ensuring compatibility with standard DICOM viewers and PACS systems. This flexibility allows for its adoption without significant changes to current imaging infrastructure.
Details
| Category | Oncology AI, Radiology & Imaging AI |
| Pricing | Unknown |
| Deployment | Cloud or on-premise. |
| Mobile App | Yes |
| API Available | Yes |
| Compliance | |
| BAA Available | Unknown |
| HIPAA Compliant | Yes AI-estimated |
| FDA Status | Cleared AI-estimated |
| GDPR | Yes AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Emergency Medicine, Pulmonology, Radiology |
FDA clearance history
This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.
| Decision date | Number | Name as listed by FDA |
| 2023-12-22 | K231805 510(k) | qXR-LN |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate qXR-LN
Videos
Product demos, reviews, and walkthroughs for qXR-LN.
No videos found. Search YouTube directly









